10.1016/j.ejphar.2016.04.004 132 StaresinicM.PetrovicI.NovinscakT.JukicI.PevecD.SuknaicS.et al (2006)
Estil, S., Steinarsson, A
Endocrinology 151:14731486 Hegedus L, Moses AC, Zdravkovic M, Le Thi T, Daniels GH (2001) GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide
Patients with renal disease also appear to lose carnitine via haemodialysis treatment a loss that cannot be repleted simply by endogenous biosynthesis and dietary intake
Short periods of mild temperature variation may not harm the medication, but its best to cool it as soon as possible
Published October 6, 2021